The Role of Life Events and HPA Axis in Anxiety Disorders: A Review

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|35|5663-5674

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.35, 2012-12, pp. : 5663-5674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of SSRIs in anxiety disorders

By Nutt D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 260-261

Elsevier

Access to resources Recommend Favorite

Stress in adolescence and drugs of abuse in rodent models: Role of dopamine, CRF, and HPA axis

By Burke Andrew   Miczek Klaus  

Psychopharmacology, Vol. 231, Iss. 8, 2014-04 ,pp. : 1557-1580

Springer Publishing Company

Access to resources Recommend Favorite

Antiepileptic Drugs in the Treatment of Anxiety Disorders: Role in Therapy

By Michael Van Ameringen   Catherine Mancini   Beth Pipe   Mark Bennett  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2199-2220

Adis International

Access to resources Recommend Favorite

Considerations in the treatment of anxiety disorders: a pharmacoeconomic review

By Grudzinski Amy Nicole  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1557-1569

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram: A Review of its Use in the Management of Anxiety Disorders

By Dhillon Sohita   Scott Lesley J.   Plosker Greg L.  

CNS Drugs, Vol. 20, Iss. 9, 2006-01 ,pp. : 763-790

Adis International

Access to resources Recommend Favorite